WCN26-3672 MONITORING OF POTASSIUM AND eGFR FOLLOWING RENIN ANGIOTENSIN SYSTEM INHIBITOR INITIATION – NECESSARY SAFETY GUIDELINE, OR COSTLY LIMIT TO OPTIMISING BP TREATMENT IN UK PRIMARY CARE?
20260 citationsJournal Articlegold Open Access
Field-Weighted Citation Impact: 0.00
WCN26-3672 MONITORING OF POTASSIUM AND eGFR FOLLOWING RENIN ANGIOTENSIN SYSTEM INHIBITOR INITIATION – NECESSARY SAFETY GUIDELINE, OR COSTLY LIMIT TO OPTIMISING BP TREATMENT IN UK PRIMARY CARE? | Researchclopedia